Multimodal therapy for tumors of the upper gastrointestinal tract;Multimodale therapie bei tumoren des oberen gastrointestinaltrakts

Chirurg

Volumn 69, Issue 4, 1998, Pages 349-359

  Fink, U ^a   Stein, H J ^a   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Barrett cancer; Esophageal cancer; Gastric cancer; Multimodal therapy

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER STAGING; CARCINOMA; ESOPHAGUS TUMOR; HUMAN; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRECANCER; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0032038109     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050424     Document Type: Article

References (63)

1. Ajani JM, Ota DM, Jessup M, Ames FC, et al (1991) Resectable gastric carcinoma: An evaluation of preoperative and postoperative chemotherapy. Cancer 68: 1501
2. Ajani JM, Mayer RJ, Ota, DM, Steele GD, et al (1993) Preoperative and postoperative chemotherapy for patients with potentially resectable gastric carcinoma. J Natl Cancer Inst 85: 1839
3. Ancona E, Ruol A, Castoro C, Chiarion-Sileni V, et al (1997) First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N,M0) squamous cell carcinoma of the thoracic esophagus. Ann Surg 226: 714
4. Ando N, Iizuka T, Kakegawa T, Isono K, et al (1997) A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 114: 205
5. Arnott SJ, Duncan W, Kerr GR, Walbaum PR, et al (1992) Low dose preoperative radiotherapy for carcinoma of the esophagus. results of a randomized clinical trial. Radiother Oncol 24: 108
6. Bamias A, Cunningham D, Nicolson V, Norman A, et al (1995) Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study. Br J Cancer 71: 583
7. Bosset JF, Gignoux M, Triboulet JP, Tirret E, et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161
8. Böttcher K, Roder JD, Busch R, Fink U, et al (1993) Epidemiologie des Magenkarzinoms aus chirurgischer Sicht. Dtsch Med Wochenschr 118: 729
9. Bumm R, Feussner H, Bartels H, Stein HJ, et al (1997) Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg 21: 822
10. Burke EC, Karpeh MS, Conlon KC, Brennan MF (1997) Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 225: 262
11. Douglass HO Jr. (1994) Adjuvant therapy of gastric cancer: Have we made any progress ? Ann Oncol [Suppl 3]5: 49
12. Findlay M, Cunningham D, Norman A, Mansi J, et al (1994) A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5 fluorouracil (ECF). Ann Oncol 5: 609
13. Fink U, Schuhmacher C, Stein HJ, Busch R, et al (1995) Preoperative chemotherapy for stage III-IV gastric carcinoma; Feasibility, response, and outcome after surgical resection. Br J Surg 82: 1248
14. Fink U, Stein HJ, Wilke HJ, Roder JD, Siewert JR (1995) Multimodal treatment for squamous cell esophageal cancer. World J Surg 19: 198
15. Fink U, Stein HJ, Schuhmacher C, Wilke HJ (1995) Neoadjuvant chemotherapy for gastric cancer: Update. World J Surg 19: 509
16. Fink U, Stein HJ, Völke K, Dittler HJ, Siewert JR (1995) Chemotherapy followed by resection for locally advanced adenocarcinoma of the esophagus or cardia. A phase II study. Abstract Book, Sixth World Congress International Society for Diseases of the Esophagus, Milan 1995, p 127
17. Fisher B, Saffer EA, Rudock C, Coyle J, Gunduzm N (1979) Effect of local or systemic treatment prior to primary tumor removal on the production and response to serum growth-stimulating factor in mice. Cancer Res 49: 2163
18. Fok M, Sham JST, Choy D, Cheng SWK, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study. Surgery 113: 138
19. Gignoux M, Roussel A, Paillot B, et al (1987) The value of preoperative radiotherapy in esophageal cancer. Results of a study of the EORTC. World J Surg 11: 426
20. Gunduz N, Fisher B, Saffer EA (1979) Effect of surgical removal on the groth and kinetics of residual tumor. Cancer Res 39: 3861
21. Hermanek P, Sobin LH (1997) UICC/TNM classification of malignant tumors. 6th rev. edn. Springer, Berlin Heidelberg New York
22. Hermans J, Bonenkamp JJ, Boon AMG, Bunt MC, et al (1993) Adjuvant therapy after curative resection for gastric cancer. J Clin Oncol 11: 1441
23. Japanese Oncology Group (1993) A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 104: 203
24. Rang Y-K, Choi D-W, Im Y-H, Kim C-M, et al (1996) A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer. Proc ASCO 15: 215
25. Kelsen D, Karpeh M, Schwartz G, Saltz L, et al (1994) Neoadjuvant and postoperative chemotherapy for high-risk gastric cancer. Proc ASCO 13: 195
26. Kelsen D (1997) Multimodal therapy for adenocarcinoma of the esophagus. Gastroenterol Clin North Am 26: 635
27. Kelsen DP, Ginsberg R, Qian C, Gunderson L, et al (1997) Chemotherapy followed by operation versus operation alone in the treatment of patients with localized esophageal cancer: a preliminary report of intergroup study 113 (RTOG 89-11). Proc ASCO 16: 276a
28. Kok TC, Lanschot J v, Siersema PD, Overhagen H v, Tilanus HW (1997) Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc ASCO 16: 277a
29. Launois B, Delarue Campion JP, et al (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153: 690
30. Law S, Fox M, Chow S, Chu K, Wong J (1997) Preoperative chemotherapy versus surgery alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114: 210
31. Le Prise E, Etienne PL, Meunier B, Maddern G, et al (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779
32. Leichman L, Silberman H, Leichman CG, Spears CP, et al (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: A University of Southern California Pilot Program. J Clin Oncol 10: 1933
33. Mathew G, Jamieson GG (1997) Neoadjuvant therapy for oesophageal cancer. Br J Surg 84: 1185
34. Nakajima T (1995) Review of adjuvant chemotherapy for gastric cancer. World J Surg 19: 570
35. Nishihira T, Nakano T, Mori S (1994) Adjuvant therapy for cancer of the thoracic esophagus. World J Surg 18: 388
36. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, et al (1992) Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy, the second Scandinavian trial in esophageal cancer. World J Surg 16: 1104
37. Plukker JT, Mulder NH, Sleijfer DTH, Grond J, Verschueren RJC (1991) Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78: 955
38. Roder JD, Böttcher K, Siewert JR, Busch R, et al (1993) Prognostic factors in gastric carcinoma: Results of the German gastric carcinoma study 1992. Cancer 72: 2089
39. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR (1994) Ratio of invaded to removed lymph modes as a predictor of survival in squamous cell carcinoma of the oesopahgus. Br J Surg 81: 410
40. Rosen HR, Scheithauer W, Jakesz R, Böhmig HJ, et al (1995) Epirubicin, Etoposide and cisplatin in the treatment of locally advanced, nonresectable gastric carcinoma - results of a multicentric pilot study. GI Cancer 1: 49
41. Roth JA, Pass HI, Flanagan MM, Graeber GM, et al (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with Cisplatin, Vindesine, and Bleomycine for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242
42. Rougier Ph, Lasser Ph, Ducreux M, Mahjoubi M, et al (1994) Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5: S59
43. Ruol A and Panel of Experts (1996) Multimodality treatment for non-metastatic cancer of the thoracic esophagus. Results of a consensus conference. Dis Esophagus 9: 39
44. Schlag P für die Chirurgische Arbeitsgemeinschaft für Onkologie der Deutschen Gesellschaft für Chirurgie Study Group (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 127: 1146
45. Sendler A, Dittler HJ, Feussner H, Nekarda H, et al (1995) Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg 19: 501
46. Siewert JR, Bartels H, Bollschweiler E, Dittler HJ, et al (1992) Plattenepithelcarcinom des Oesophagus: Behandlungskonzepte der Chirurgischen Klinik der Technischen Universität München. Chirurg 63: 693
47. Siewert JR, Fink U (1992) Multimodale Therapieprinzipien bei Tumoren des Gastrointestinaltrakts. Chirurg 63: 242
48. Siewert JR, Stein HJ (1996) Adenocarcinoma of the gastroesophageal junction: Classification, pathology and extent of resection. Dis Esophagus 9: 173
49. Siewert JR, Stein HJ, Böttcher K (1996) Lymphadenektomie bei Tumoren des oberen Gastrointestinaltrakts. Chirurg 67: 977
50. Siewert JR, Stein HJ, Sendler A (1997) Chirurgische Relevanz bildgebender Diagnostik bei Tumoren des Gastrointestinaltrakts - Entscheidungswege beim Oesophagus-, Magen, Colon-und Rectumcarcinom. Chirurg 68: 317
51. Siewert JR, Stein HJ (1997) Barrett's cancer: Indications, extent and results of surgical resection. Semin Surg Oncol 13: 245
52. Siewert JR, Fink U, Sendler A, Decker K, et al (1997) Gastric cancer. Curr Probl Surg 34: 835
53. Stein HJ, Fink U (1997) Adjuvante und neoadjuvante Therapie beim Oesophaguscarcinom. Chirurg Gastroenterol 13: 6
54. Stein HJ, Kraemer SJM, Feussner H, Siewert JR (1997) Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia. J Gastrointest Surg 1: 167
55. Stein HJ, Fink U, Siewert JR (1994) Who benefits from combined modality treatment of esophageal carcinoma? Dis Esophagus 7: 156
56. Teniere P, Hay J-M, Fingerhut A, Fagniez P-L (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the midlle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 173: 123
57. Urba S, Orringer M, Turrisi A, Whyte R, et al (1997) A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis. Proc ASCO 16: 277a
58. Walsh TN, Noonan N, Hollywood D, et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462
59. Walsh TN, Noonan N, Hollywood D, Kelly A, et al (1996) Multimodality treatment plus surgery versus surgery alone for oesophageal squamous cell carcinoma. In: Peracchia A (ed) Recent advances in diseases of the esophagus. Monduzzie Editori, Bologna, p 451
60. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, et al (1993) Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 218: 583
61. Wang M, Gu XZ, Yin W, et al (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma. Report on 206 patients. Int J Radiat Oncol Biol Phys 16: 325
62. Wilke H, Preusser P, Fink U, Gunzer U, et al (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase II study with etoposide, doxorubicin and cisplatin. J Clin Oncol 7: 1318
63. Wilke HJ, Fink U (1989) Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. N Engl J Med 335: 509